Figure 2From: Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balanceCardiovascular risk in patients with arthritis: celecoxib versus NSAIDs, naproxen, or placebo. Shown is a summary of the risk for death, myocardial infarction, and stroke for celecoxib relative to nonsteroidal anti-inflammatory drugs (NSAIDs), naproxen, or placebo in patients with arthritis [30]. *P = nonsignificant. Reproduced with permission from Elsevier [30].Back to article page